Pfizer hires a new chief scientific officer for its neuroscience business

Comments Print By Jon Chesto Globe Staff  September 07, 2016 Pfizer Inc. has hired a well-known expert in neurodegenerative diseases to be the drug maker’s new chief scientific officer for its nueroscience research division in Cambridge. Ole Isacson will replace Michael Ehlers, who left Pfizer to take a top executive position at neighboring Biogen earlier this year. Isacson currently is a neurology professor at Harvard Medical School and founding director of the Neuroregeneration Research Institute at McLean Hospital in Belmont. Isacson has built a reputation for, among other things, his expertise in researching ways to fight Parkinson’s disease. He’ll start at Pfizer next week, and will report to Mikael Dolsten, Pfizer’s president of worldwide research and development. Dolsten cited Isacson’s strong ties to the local academic community, saying those ties…


Link to Full Article: Pfizer hires a new chief scientific officer for its neuroscience business